Biotech News

BD to Announce Financial Results for its Third Quarter of Fiscal 2026

Becton Dickinson (BDX)Becton DickinsonEarnings

, /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, August 6, 2026 to discuss the Company's financial results for its third quarter of fiscal year 2026, which ended on June 30, 2026, and to provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors , and a replay will be made available shortly after the call at the same website. Prior to the call, the Company will issue a news release and related presentation materials that will include summary financial information for the quarter. The news release and related presentation materials will be made available at www.bd.com/investors .

About BD BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health™ by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X @BDandCo or Instagram @becton_dickinson .

View original content: https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-third-quarter-of-fiscal-2026-302822219.html

SOURCE BD (Becton, Dickinson and Company)

Released July 9, 2026

Related news

Becton Dickinson

Global Medical Technology BD is a large medical-technology company supplying products used across medication delivery, connected care, biopharmaceutical manufacturing and interventional procedures. Medical Essentials The company manufactures needles, syringes, catheters, vascular-access products and other high-volume devices used...

Recent company news

Stock data

Close
177.07 USD
Market cap
39.8B USD
Exchange
NYSE
Sector
Biopharma
Location
United States